Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
12.62
-0.32 (-2.47%)
At close: Nov 3, 2025, 4:00 PM EST
12.50
-0.12 (-0.95%)
After-hours: Nov 3, 2025, 5:34 PM EST

Nurix Therapeutics Balance Sheet

Millions USD. Fiscal year is Dec - Nov.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2019
Period Ending
Aug '25 Nov '24 Nov '23 Nov '22 Nov '21 Nov '20 2018 - 2019
Cash & Equivalents
78.4411054.6364.4780.51119.36
Upgrade
Short-Term Investments
350.39499.59233.28244.67215.21161.79
Upgrade
Cash & Short-Term Investments
428.83609.58287.91309.14295.72281.15
Upgrade
Cash Growth
-4.29%111.73%-6.87%4.54%5.18%645.36%
Upgrade
Accounts Receivable
----67.5
Upgrade
Other Receivables
1.71.50.81.11.14.25
Upgrade
Receivables
1.71.50.81.17.111.75
Upgrade
Prepaid Expenses
10.078.36.88.218.295.54
Upgrade
Total Current Assets
440.6619.39295.5318.45311.12298.43
Upgrade
Property, Plant & Equipment
73.5345.947.9529.5125.356.67
Upgrade
Long-Term Investments
--7.4263.88137.1990.89
Upgrade
Long-Term Deferred Charges
-0.10.50.50.5-
Upgrade
Other Long-Term Assets
8.343.964.224.422.620.35
Upgrade
Total Assets
522.47669.34355.6416.76476.77396.34
Upgrade
Accounts Payable
8.6111.486.45.066.653.41
Upgrade
Accrued Expenses
41.334.4824.1920.8413.827.55
Upgrade
Current Portion of Leases
3.798.017.495.533.85-
Upgrade
Current Income Taxes Payable
0.931.240.030.090.080.07
Upgrade
Current Unearned Revenue
25.9938.3648.137.6341.2132.8
Upgrade
Other Current Liabilities
1.732.280.751.50.660.7
Upgrade
Total Current Liabilities
82.3595.8586.9670.6666.2644.54
Upgrade
Long-Term Leases
52.720.2923.136.439.19-
Upgrade
Long-Term Unearned Revenue
15.1826.2145.0235.9759.0260.69
Upgrade
Other Long-Term Liabilities
-----0.85
Upgrade
Total Liabilities
150.22142.35155.11113.06134.47106.07
Upgrade
Common Stock
0.080.080.050.050.050.04
Upgrade
Additional Paid-In Capital
1,2971,266746.3709.22563.76393.84
Upgrade
Retained Earnings
-925.01-738.77-545.2-401.25-220.89-103.7
Upgrade
Comprehensive Income & Other
0.120.15-0.66-4.32-0.610.09
Upgrade
Total Common Equity
372.25526.99200.49303.7342.3290.27
Upgrade
Shareholders' Equity
372.25526.99200.49303.7342.3290.27
Upgrade
Total Liabilities & Equity
522.47669.34355.6416.76476.77396.34
Upgrade
Total Debt
56.4928.330.6111.9613.04-
Upgrade
Net Cash (Debt)
372.34581.28264.72361.06419.87281.15
Upgrade
Net Cash Growth
-13.48%119.59%-26.68%-14.01%49.34%645.36%
Upgrade
Net Cash Per Share
4.518.664.877.439.7917.94
Upgrade
Filing Date Shares Outstanding
76.8875.8948.8947.2744.7438.91
Upgrade
Total Common Shares Outstanding
76.8775.8748.7247.1744.6638.86
Upgrade
Working Capital
358.25523.53208.55247.79244.86253.9
Upgrade
Book Value Per Share
4.846.954.126.447.667.47
Upgrade
Tangible Book Value
372.25526.99200.49303.7342.3290.27
Upgrade
Tangible Book Value Per Share
4.846.954.126.447.667.47
Upgrade
Machinery
46.0241.0433.8327.6219.315.37
Upgrade
Leasehold Improvements
9.065.143.243.833.082.66
Upgrade
Updated Oct 9, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q